Subsequently, CD70 has been found to be overexpressed in renal cell carcinoma (RCC) [19–21], adenocarcinoma of pancreas and ovaries, breast and colon cancer, glioblastoma, laryngeal carcinoma and melanoma [15, 22, 23]. This evidence concerns the gene CD70 and renal cell carcinoma.